At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,046 enrolled
Drug / intervention
Alertother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Uplift Modeling to More Narrowly Target Alerts for Acute Kidney Injury
In Brief
A clinical study evaluating Alert for Acute Kidney Injury. Completed, enrolled 2,046 participants across 1 site.
Detailed Summary
The primary objective of this study is to determine whether the use of uplift (also known as Conditional Average Treatment Effect - CATE) modeling to empirically identify patients expected to benefit the most from AKI alerting and to target AKI alerts to these patients will reduce the rates of AKI progression, dialysis, and mortality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartFeb 2024
Primary CompletionAug 2024
Study CompletionMay 2025
TodayJul 2026
First PostedMay 30, 2016
Enrollment StartFeb 15, 2024
Primary CompletionAug 14, 2024
Study CompletionMay 3, 2025
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.1 years ago
Interventions
Alertother
An alert informing the provider of the presence of acute kidney injury will be fired.